Global Tobacco and Nicotine Forum (GTNF): Shaping the Future

Dec.30.2022
The Global Tobacco and Nicotine Forum (GTNF) brings together experts and government representatives annually to discuss the industry's future.

The Global Tobacco and Nicotine Forum (GTNF) is one of the most influential forums in the global tobacco and nicotine industry. Since its inception in Rio de Janeiro, Brazil in 2008, the event has attracted hundreds of global public health experts, government representatives including those from food and drug regulatory agencies, industry leaders, and investors, all coming together to discuss the future direction of the industry.


The sixth edition of the Global Tobacco & Nicotine Forum (GTNF) is set to take place, bringing together industry leaders, experts, and stakeholders to discuss and explore the latest trends and developments in the tobacco and nicotine sector. This prestigious event aims to provide a platform for meaningful discussions, knowledge sharing, and networking opportunities that will shape the future of the industry. Hosted by GTNF, the conference promises to deliver valuable insights and perspectives on key issues affecting the global tobacco and nicotine market. With a focus on fostering collaboration, the GTNF 6 conference is anticipated to offer a dynamic and engaged environment for attendees to gain a deeper understanding of the industry's challenges and opportunities.


Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.

MGH Study: Varenicline Boosts Young Adults’ E-Cigarette Quit Rates by 50%
MGH Study: Varenicline Boosts Young Adults’ E-Cigarette Quit Rates by 50%
A study by Massachusetts General Hospital found that the oral smoking cessation drug varenicline significantly improves e-cigarette quit rates among young people aged 16 to 25. In a 12-week trial, 50% of participants in the varenicline group successfully quit vaping, compared to just 14% in the placebo group. After six months, 28% of those in the treatment group remained vape-free.
Apr.24 by 2FIRSTS.ai
Malaysia to Remove Unregistered Vaping Products by October, Says Health Ministry
Malaysia to Remove Unregistered Vaping Products by October, Says Health Ministry
Malaysia’s Ministry of Health expects to complete the registration and approval process for vaping products by October. Products not included in the official registry will be banned from sale.
Jun.11 by 2FIRSTS.ai
New Markets, New Opportunities: 2Firsts to Host Global NGP Market Trends Forum on June 6
New Markets, New Opportunities: 2Firsts to Host Global NGP Market Trends Forum on June 6
2Firsts will host the Global NGP Market Trends Forum on June 6 in Shenzhen, focusing on trends in e-cigarettes, heated tobacco, and oral nicotine. Experts will explore industry shifts and growth opportunities across the global nicotine market.
May.22
U.S. FDA Unveils AI Tool Elsa for Clinical Review, Internal Writing, and Data Processing
U.S. FDA Unveils AI Tool Elsa for Clinical Review, Internal Writing, and Data Processing
The U.S. Food and Drug Administration has officially launched Elsa, a generative AI tool designed to speed up clinical reviews, internal writing, and data processing tasks. After successful pilots across multiple departments, Elsa is now being rolled out agency-wide.
Jun.04 by 2FIRSTS.ai
BAT Plans to Appoint New Chairman, Successor Expected by 2026
BAT Plans to Appoint New Chairman, Successor Expected by 2026
British American Tobacco is seeking a successor for chairman Luc Jobin, who will step down in 2026 due to governance rules.
Jun.10 by 2FIRSTS.ai
Vermont adult smoking rate drops, youth e-cigarette use increases significantly
Vermont adult smoking rate drops, youth e-cigarette use increases significantly
Vermont adult smoking rates decrease while youth e-cigarette usage rises, driven by flavored tobacco products.
Apr.21 by 2FIRSTS.ai